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ABSTRACT Widespread use of unsafe sexual practices among women injecting drugs
both practicing and not practicing sex work leads to high levels of unplanned
pregnancies in this population. The goal of this study was to investigate the
association between pregnancy and active drug use and sex work. Data were
collected using a convenience sample of 500 women in Saint Petersburg, Russia, in
2013. All women had recent experience of drug use, of which 200 were pregnant at the
time of the study. The study consisted of a structured interview followed by a rapid HIV
test. Pregnancy was protective against both active drug use and sex work. For HIV-
positive women, these associations were stronger than for HIV-negative women: drug
use prevalence ratio (PR) was 0.59 vs 0.85; for sex work, the PRs were 0.36 vs 0.64.
Higher levels of education were associated with a lower prevalence ratio for active drug
use and sex work in all models. Having children was not associated with active drug use
or sex work. Pregnancy might be an optimal time for conducting interventions aimed at
cessation of drug use and sex work among women injecting drugs.
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INTRODUCTION
TheHIVepidemic in the Russian Federation continues to remain one of the fastest growing
HIV epidemics worldwide.1 As of the end of 2013, HIV prevalence in the Russian
Federation was 468.8 per 100,000 of population; in total, 800,531 people were registered
with HIV.2 Those ofﬁcially registered with HIV infection are patients who were non-
anonymously tested at the state medical facility, tested positive on the enzyme-linked
immunosorbent assay (ELISA) test, and conﬁrmed by theWestern blot. It is suggested that
ofﬁcial data seriously underestimate the real HIV prevalence in the Russian Federation.3,4
From the beginning of the HIV epidemic in the Russian Federation, injection drug
users (IDUs) were the most affected group with the main route of HIV transmission
through infected syringes.5 Presently, heterosexual HIV transmission is increasing:
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42 % of 79,728 people diagnosed with HIV in 2013 in the Russian Federation were
infected through heterosexual sex.2 However, IDUs continue to comprise a
substantial proportion of people infected with HIV.6
Previous research demonstrates that, among women, the use of illegal drugs and
unsafe sexual practices are correlated. Some studies suggest that around 40 % of
women IDUs (WIDUs) are involved in transactional sex or commercial sex work7,8
and between 20 and 80 % of the women engaged in sex work also inject drugs.9
Because of sex work and unsafe sexual behaviors, WIDUs may serve as a bridge of
HIV transmission to the general population.10
Studies have shown a high prevalence of unsafe sexual practices among WIDUs.
One such study’s ﬁnding was that only 22 % of WIDUs in Saint Petersburg reported
consistently using condoms.11 This, in turn, leads to a high level of unplanned and
unwanted pregnancies11,12 resulting in both higher levels of pregnancy termina-
tions13 and increased number of births among WIDUs.14
Pregnancy, complicated by injection drug use and positive HIV status and/or
other sexually transmitted infections, raises many public health issues. These include
mother-to-child HIV and drug addiction transmissions, abandonment of infants by
HIV-positive mothers,15 and health complications for the mother and the baby.16
Nevertheless, for women using drugs, pregnancy might be an optimal time for
interventions aimed not only at prevention of mother-to-child HIV transmission but
also at treatment of drug addiction. Massey17 found that women’s motivation to
change their substance use behaviors during pregnancy is high; additionally, the
cessation of injection drug use would not only improve the health of newborns but
may also lead to safer sexual practices. These interventions might result in
decreasing the levels of HIV infection and HIV transmission in the population.
The purpose of this study is to assess the associations between pregnancy and
active injection drug use and active sex work in a convenience sample of women
injection drug users in Russia.
METHODS
Setting
Saint Petersburg is the second largest city in Russia with a population of 5.3 million
people or 3.2 % of the total population of Russia.18 The estimated number of IDUs
in Saint Petersburg is between 30,000 and 80,000,19 with the estimated HIV
prevalence among IDUs which ranges between 40 and 64 %.6,19
There are no reliable data available on the sex distribution among IDUs in Saint
Petersburg, but some data indicate that women comprise between 20 and 40 % of the
total number of IDUs.7,11 Unpublished data collected from 1006 respondents by one of
the largest harm reduction programs in Saint Petersburg (HumanitarianAction)20 suggest
that the proportion of women among IDUs in Saint Petersburg might be as high as 45%.
Study Population
A convenience sample of women was recruited who were current or past injection
drug users and had either (1) received harm reduction services at an outreach
program tailored for women or (2) participated in a case management program
designed to assist pregnant women using drugs. Both programs are implemented by
the fund Humanitarian Action. Women who participated in these programs between
May and October of 2013 were invited to participate in the study by the program’s
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staff. Following agreement, a trained interviewer conducted all study procedures
with the exception of the blood tests which were performed by a certiﬁed nurse.
Additional women not participating in Humanitarian Action programs were
recruited by word of mouth as information about the study spread through the
community of female drug users in Saint Petersburg.
The inclusion criteria for the study were women aged 18 and 48 years with recent
experience of injection drug use (deﬁned as at least one injection during the previous
6 months). The lower age limit was determined by Russian regulations on
performing HIV tests: only persons aged 18 and older can legally provide informed
consent for HIV testing; the highest age limit was chosen to reﬂect the reproductive
years.
Women were informed that their participation or refusal to participate in this
study would not affect their receiving programmatic services from Humanitarian
Action. Women who chose to participate in the study completed face-to-face
interviews using a structured questionnaire and underwent rapid HIV testing (Alere
Determine HIV1/HIV2; Waltham, MA, USA). Rapid testing for HIV was preceded
by pre-test counseling and followed by post-test counseling according to Russian
regulations. In the case of a positive test result, women were referred to a medical
facility for HIV diagnosis, since according to Russian regulations, rapid tests are not
diagnostic instruments and might only serve as motivators to seek medical care.
Participants were offered a phone card worth $10 as an incentive. Participation in
the study was completely anonymous, participants provided no identifying
information: instead of a name, an individual depersonalized code was used. In
addition, to provide absolute anonymity, instead of date of birth, only the year of
birth was collected. Study protocol was approved by the local IRB; all women who
choose to participate in the study have signed written inform consent form.
In total, of 584 women invited to participate, 534 were eligible, and of these, 500
(94 %) provided informed consent and took part in the study. Two hundred of these
were pregnant at the time of their interview. Since the study goal was to assess
associations between risk behaviors and pregnancy, pregnant women were
oversampled: the initial goal of recruitment was set up to recruit at least 500
women of which 200 should be pregnant.
Data Analysis
Descriptive statistics were calculated (means and medians) for continuous variables
and frequencies and percentages for categorical variables. Bivariate analyses were
conducted to assess differences between women who were pregnant at the time of
study and those who were not, and included t tests for continuous variables and χ2
square tests for categorical variables. Previous research has found prevalence ratios
(PRs) to be an appropriate effect measure for cross-sectional studies21 in which the
outcomes were common. Thus, log-binomial regression, which has been proven to
calculate PR accurately,22 was chosen to measure the associations of interest. To
assess the PR of active drug use and/or active sex work among pregnant women
compared to non-pregnant women, two models were constructed using pregnancy
status (yes/no) as the primary predictor variable. Additional covariates included age,
education, and parental status. Age and education were found to be important
confounders in other studies.12 Little is known about parental status as a potential
confounder of the association between pregnancy and active injection drug use and/
or sex work, but some evidence indicates it might be a confounder.23,24 All potential
covariates were associated both with exposure and the outcomes in bivariate
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analyses and met the criteria for being potential confounders according to
constructed directed acyclic graphs (DAGs). Based on DAG, HIV status did not
meet the criteria for being a confounder as it is a consequence of risky behaviors; it is
a surrogate for sharing needles and/or having sex without condoms in the past and
thus might potentially be related to changes in drug use/sex work. Thus, it is a
potential effect modiﬁer. To assess potential differences in associations between
exposure and both outcomes for HIV-positive and HIV-negative women, interaction
terms between the main exposure (pregnancy) and HIV status (positive/negative)
were included in the both models. Since active drug use and sex work are highly
correlated, it was not feasible to include these variables as additional covariates in
the corresponding models. Data were analyzed using SAS 9.3 software (SAS Institute
Inc., Cary, NC, USA).
RESULTS
Descriptive characteristics of the sample are presented in Table 1. The mean age of
the women was 31 years (range 18–47 years); 86.2 % had at least a high school
education, and 13.8 % had post college education. Only 7.6 % of the women
reported that they had never been pregnant during their life, 71.6 % had had at least
one abortion, and 71 % had children. Forty percent were pregnant at the time of the
study, and 22.3 % reported that they had realized their last or current pregnancy
after 12 weeks of gestation. According to Russian regulations, 12 weeks is the cutoff
point after which elective abortions cannot be performed. Approximately 75 % of
the women reported active drug use, and 41.4 % said that they were actively
practicing sex work at the time of the study. Rapid HIV tests were positive for
62.9 % of the study population.
The proportion of HIV-positive results was signiﬁcantly higher among the
pregnant women than among women who were not pregnant at the time of study:
76.5 vs 54 % (pG0.0001, Table 1). On average, women who were pregnant at the
time of study were younger, more likely to already have children and be HIV
positive, and less likely to be actively using drugs and engaging in sex work. Women
who were pregnant at the time of study discovered their current pregnancy later
than women who were not pregnant at the time of study and discovered their last
pregnancy (p=0.009): 29.7 % of women who were pregnant at the time of study
discovered their pregnancy after 12 weeks vs 16.8 % of non-pregnant women who
discovered their last pregnancy after 12 weeks.
Engagement in active sex work was associated with a lower proportion of HIV-
positive test results (54.5 vs 68.6 %, p=0.002).
Multivariate Analysis
Active Drug Use To assess potential effect modiﬁcation by HIV status, the model
was run with an interaction term for pregnancy status and HIV status. Since HIV
status was shown to modify the association between pregnancy and drug use
(interactive term: p=0.003), analysis was stratiﬁed on HIV status.
The prevalence ratio of active drug use among pregnant HIV-positive WIDU was
lower compared to non-pregnant HIV-positive WIDU (PR=0.59). Although a higher
level of education was shown to be protective against active drug use during
pregnancy compared to high school level, it did not confound the association
between pregnancy and active drug use. Age and parental status were not found to
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be confounders. Thus, age and parental status were not included in the ﬁnal model
(Table 2).
For HIV-negative WIDU, the association between pregnancy and active drug use
was found to be weaker than for HIV-positive women, but still statistically
TABLE 1 Characteristics of study population in 2013
Characteristic Total Pregnant Not pregnant p value
Mean age (SD), years 31.0 (4.8) 29.6 31.9 G0.001
Education, n (%)
Unﬁnished high school 69 (13.8) 36 (12.0) 33 (16.5) 0.13
High school 210 (42.0) 120 (40.0) 90 (45.0)
Some college 152 (30.4) 102 (34.0) 50 (25)
Post college education 69 (13.8) 42 (14.0) 27 (13.5)
Pregnancy at the time of interview, n (%)
No 300 (60.0)
Yes 200 (40.0)
Ever been pregnant, n (%)
No 38 (7.6)
Yes 462 (96.4)
Parental status, n (%)
No 145 (29.0) 19 (9.5) 126 (42) G0.001
Yes 355 (71.0) 181 (90.5) 174 (58.0)
Ever had an abortion, n (%)
No 142 (28.4) 75 (37.5) 110 (36.9) 0.92
Yes 358 (71.6) 125 (62.5) 188 (63.1)
HIV status, n (%)
Negative 184 (37.1) 46 (23.5) 138 (46) G0.001
Positive 312 (62.9) 150 (76.5) 162 (54)
Active drug use at the time of interview, n (%)
No 126 (25.2) 86 (43) 40 (13.3) G0.001
Yes 374 (74.8) 114 (57) 260 (86.7)
Active sex work at the time of interview, n (%)
No 293 (58.6) 152 (76) 141 (47) G0.001
Yes 207 (41.4) 48 (24) 159 (53)
Discovered current/last pregnancy after 12 weeks, n (%)
No 358 (77.7) 140 (70.3) 218 (83.3) G0.001
Yes 103 (22.3) 59 (29.5) 44 (16.8)
TABLE 2 Prevalence ratio of active drug use in pregnant HIV-positive WIDUs compared to non-
pregnant HIV-positive WIDUs (N=312)
Crude PR (95 % CI) Adjusteda PR (95 % CI)
Pregnancy status 0.59 (0.50, 0.70) 0.60 (0.51, 0.71)
Education
Unﬁnished high school 1.01 (0.88, 1.15)
High school 1.0
Some college 0.88 (0.75, 1.02)
Post college 0.72 (0.52, 0.99)
aAdjusted for education
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signiﬁcant after adjusting for education (PR=0.85). A higher level of education was
also found to be protective against active drug use during pregnancy comparing to
high school level but was not a confounder of the association between pregnancy
and active drug use (Table 3). Overall, a protective effect of pregnancy against active
drug use was seen among both HIV-positive and HIV-negative women; the effect
was more pronounced in HIV-positive women.
Active Sex Work As with the drug use models, an interactive term with pregnancy
and HIV status was included to test for effect modiﬁcation. The interaction term for
HIV status and pregnancy was found to be statistically signiﬁcant (p=0.042); thus,
stratiﬁed models were run for HIV-positive and HIV-negative women (Tables 4 and
5). Age and parental status were not statistically signiﬁcant and did not confound
the association of interest. Although a higher level of education appears to be a
protective factor against active sex work during pregnancy both in HIV-positive and
HIV-negative women, it does not confound the association between pregnancy and
active sex work.
The negative association between pregnancy status and active sex work was
stronger than the negative association between pregnancy status and active sex drug
use. For HIV-positive WIDU, this association was stronger than for HIV-negative
WIDU (PR=0.36 vs PR=0.64).
DISCUSSION
Our study found pregnancy to be inversely associated with active drug use, and for
HIV-positive women, this association was stronger. Similarly, a stronger inverse
TABLE 3 Prevalence ratio of active drug use in pregnant HIV-negative WIDUs compared to
non-pregnant HIV-negative WIDUs (N=184)
Crude PR (95 % CI) Adjusteda PR (95 % CI)
Pregnancy status 0.85 (0.72, 1.01) 0.85 (0.72, 1.0)
Education
Unﬁnished high school 0.99 (0.88, 1.11)
High school 1.0
Some college 0.94 (0.84, 1.05)
Post college 0.73 (0.58, 0.93)
aAdjusted for education
TABLE 4 Prevalence ratio of active sex work in HIV-positive pregnant WIDUs compared to
non-pregnant WIDUs (N=312)
Crude OR (95 % CI) Adjusteda PR (95 % CI)
Pregnancy status 0.36 (0.25, 0.53) 0.36 (0.25, 0.52)
Education
Unﬁnished high school 1.12 (0.83, 1.52)
High school 1.0
Some college 0.60 (0.42, 0.86)
Post college 0.35 (0.15, 0.79)
aAdjusted for education
PREGNANCY, INJECTION DRUG USE, AND SEX WORK IN ST. PETERSBURG 553
association between pregnancy and active sex work was found, with HIV-positive
women almost two times less likely to actively practice sex work comparing to HIV-
negative WIDU. Higher levels of education were found to be protective against both
active drug use and active sex work during pregnancy, and it played a more
signiﬁcant role as a protective factor against sex work than drug use among
pregnant WIDU. However, having prior children was not associated with either
active drug use or active sex work among both HIV-positive and HIV-negative
women. One explanation for this might be that WIDU is motivated to stop risky
behaviors when they are pregnant, but the period of motivation to discontinue drug
use and sex work might be limited to the period of pregnancy. This explanation is
supported by ﬁndings from another study where pregnancy was associated with
increased motivation to decrease drug use.23
Women who were pregnant at the time of study had signiﬁcantly higher
prevalence of HIV infection, discovered their current pregnancy later than non-
pregnant women discovered their last pregnancy, and were more likely to already
have children. This suggests that women who are engaged in unsafe sexual practices
are more likely both to be HIV infected and pregnant. In contrast, women who
reported actively practicing safe sex work were less likely both to be HIV positive
and pregnant. This is in concordance with ﬁndings from other studies where
practicing sex work was associated with lower levels of unsafe sex behaviors and
higher level of condom use among WIDUs.25 These ﬁnding also suggest that
interventions aimed at decreasing risky sexual behaviors would be beneﬁcial both
for addressing HIV spread and preventing unplanned and unwanted pregnancies in
the population of WIDU.
Prevalence estimation of HIV infection in the study population (63 %) may not
adequately reﬂect the prevalence of HIV in the total population of WIDU;
nevertheless, this ﬁnding is alarming and indicating a serious problem concerning
the spread of HIV among IDUs and WIDUs, which agrees ﬁndings of other
studies.26,27 In 2008, it was estimated that HIV seroprevalence among injection drug
users in the Russian Federation was 37.2 %.3 Findings from the present study might
indicate that among female injection drug users, this number might have
signiﬁcantly increased during the last 5 years. Policies aimed at criminalization of
drug use and sex work in Russia have not only led to further marginalization of
populations involved in these activities but also created barriers in accessing HIV
care facilities.28 These factors, combined with the absence of stable systematic
prevention programs proven to be effective in stopping HIV epidemic in vulnerable
TABLE 5 Prevalence ratio of active sex work in pregnant HIV-negative WIDUs compared to
non-pregnant HIV-negative WIDUs (N=184)
Crude PR (95 % CI) Adjusteda PR (95 % CI)
Pregnancy status 0.63 (0.42, 0.96) 0.64 (0.42, 0.96)
Education
Unﬁnished high school 1.03 (0.72, 1.47)
High school 1.0
Some college 0.65 (0.46, 0.92)
Post college 0.61 (0.38, 0.98)
aAdjusted for education
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populations, have resulted in the continuous growth of HIV infection among these
groups.
Taking into account the severely high level of HIV seroprevalence among
pregnant WIDUs in our study, it is not surprising that Saint Petersburg experiences
the highest number of deliveries in Russia given by HIV-positive mothers.14
Limitations
As with all cross-sectional studies, the temporality of exposure and outcomes cannot
be ascertained. Thus, in this study, it was impossible to establish whether exposure
to pregnancy preceded the outcomes. However, cross-sectional studies are conve-
nient for the purposes of exploration and generation of new hypotheses for further
research. Despite the limitations of cross-sectional study design, it was appropriate
for this study, since this was a new exploration of the intersections of pregnancy,
injection drug use, and sex work.
Since the population of injection drug users in Saint Petersburg is highly
stigmatized and largely hidden, and WIDUs are subjected to even greater
stigmatization than male IDUs, convenience sampling was necessary as it was not
feasible to use a random sampling frame to study this population. Thus, inferring
the results of this study onto the population of WIDUs is limited.
Another limitation is that rapid tests do not register acute HIV infections; thus,
the prevalence of HIV in the study population might potentially be underestimated.
Selection bias may be present since the majority of study participants were
women who use programs targeting injection drug users. These women may have
different characteristics when compared to women who do not participate in such
programs.
Finally, since injection drug use during pregnancy is highly stigmatized behavior,
especially when combined with HIV-positive status,29 a response bias might have
been introduced among those women who reported not using drugs during
pregnancy. As with barriers to seeking HIV care discussed above,28 it was thought
that women who were actively using drugs would also not seek medical care for
their pregnancy. Therefore, to assess the potential size of the response bias, the
proportion of women who reported seeking medical care for their pregnancy was
compared between women who indicated active drug use and who reported not
currently using drugs. It was thought that women who misreported their drug use
and were in fact using drugs would also not seek medical care. The results showed
that 43 % of current drug users sought care, while 83 % of those who reported not
using drugs sought care (pG0.0001). If those classiﬁed as non-drug users did in fact
use drugs, the expected proportion among the non-active drug users would be closer
to that of the active drug users. However, the proportion among the non-active drug
users is almost double that of the active users providing some evidence that the
response bias is not large.
Strengths
The sample size of this study is larger than any recent prior study conducted among
women injecting drugs in Saint Petersburg during recent years. In addition, the 150
HIV-positive pregnant women with experience of intravenous drug use in this study
represent 20 to 30 % of the known number of HIV-positive women who give birth
in Saint Petersburg yearly. According to internal statistics of the two maternity
houses where mothers with unknown or established HIV-positive status give birth,
about 500 births by HIV-positive mothers are given in Saint Petersburg yearly.
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An objective assessment of HIV status was determined by the use of rapid test
rather than the women reporting their status. The estimate of HIV prevalence in this
study might not reﬂect the actual prevalence among WIDUs, but it might provide
HIV status information about the source population and directions for further
investigation.
CONCLUSIONS
Findings from this study support the need to urgently develop public health
interventions for women injecting drugs. Thirty percent of currently pregnant
WIDUs found out about their pregnancies after 12 weeks of gestation, eliminating
the opportunity to cease drug use during the ﬁrst trimester or legally terminate the
pregnancy. Other studies conducted in Saint Petersburg have demonstrated that
WIDUs need comprehensive intervention programs aimed at primary, secondary,
and tertiary prevention of HIV infection;30,31 prevention of unplanned and
unwanted pregnancies;11,12 and assistance in changing risk behaviors in pregnant
WIDUs.
Strong associations found in this study suggest that the targeted implemen-
tation of effective intervention programs for pregnant women using drugs could
potentially have a substantial public health impact. In the absence of stable
sustainable programs aimed to provide comprehensive social, medical, and drug
addiction care for pregnant WIDUs, our study found that pregnancy is still
associated with lower prevalence of active drug use and sex work. Thus, one
might infer that during pregnancy, the WIDUs’ motivation to change behaviors
negatively affecting their health is considerable. The potential effect of targeted
programs for pregnant WIDU addressing the prevention of vertical transmission
of HIV, providing comprehensive assistance in treating drug addiction, and
creating social conditions allowing discontinuing sex work might be signiﬁcant
in terms of improved health status of newborns and mothers and prevention of
further spread of HIV and other blood-borne and sexually transmitted
infections. The ﬁndings that the period of motivation for changing negatively
affecting health behaviors might be restricted to the period of pregnancy impose
even greater public health signiﬁcance on potential intervention programs
tailored for pregnant WIDUs. Additionally, the ﬁnding that HIV-positive women
were less likely to actively use drugs during pregnancy compared to HIV-
negative women suggests that different types of interventions should be
designed for HIV-positive and HIV-negative women.
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